FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980732912> ?p ?o ?g. }

• W2980732912 endingPage "1779" @default.
• W2980732912 startingPage "1772" @default.
• W2980732912 abstract "Sex differences may modify symptoms, disease expression, and treatment effects. The objective of this study was to evaluate the link between life impact and sex in psoriatic arthritis (PsA).Remission and Flare in Psoriatic Arthritis (ReFlaP; ClinicalTrials.gov identifier: NCT03119805) was a study in 14 countries of consecutive adult patients with definite PsA. Participants underwent comprehensive PsA assessment using the following measures: Disease Activity in Psoriatic Arthritis (DAPSA), Minimal Disease Activity (MDA), and Psoriatic Arthritis Impact of Disease (PsAID). Disease activity was compared by sex using t-tests or Wilcoxon tests. The association of PsAID with sex was analyzed using hierarchical generalized linear models.Of 458 participants, 50.2% were male and the mean ± SD age was 53.1 ± 12.6 years. The mean ± SD PsA duration was 11 ± 8.2 years, and 51.5% of participants were being treated with biologic disease-modifying antirheumatic drugs. Women, compared to men, had worse mean ± SD Leeds Enthesitis Index scores (0.8 ± 1.7 versus 0.3 ± 0.9), pain on a numerical rating scale (NRS; range 0-10) (4.7 ± 2.7 versus 3.5 ± 2.7), HAQ DI scores (0.9 ± 0.7 versus 0.5 ± 0.6), fatigue on an NRS (5.2 ± 3 versus 3.3 ± 2.8), and PsAID scores (4.1 ± 2.4 versus 2.8 ± 2.3) (P < 0.001 for all). Women were also less frequently at treatment target compared to men according to DAPSA (cutoffs of ≤4 for remission and >4 and ≤14 for low disease activity; mean ± SD score 16.9 ± 14.9 in women versus 12.6 ± 16.6 in men) and MDA (25.7% versus 50.0%; P < 0.001 for all) scores. High life impact (PsAID score ≥4) was associated with female sex (odds ratio [OR] 2.3), enthesitis (OR 1.34), tender joints (OR 1.10)(P < 0.001 for all), and comorbidities (OR 1.22, P = 0.002).High life impact was independently associated with female sex, enthesitis, comorbidities, and tender joints. At treatment target, women had higher life impact compared to men. It is necessary for life impact to become a part of PsA treat-to-target strategies." @default.
• W2980732912 created "2019-10-25" @default.
• W2980732912 creator A5001947020 @default.
• W2980732912 creator A5005788294 @default.
• W2980732912 creator A5009722499 @default.
• W2980732912 creator A5012917558 @default.
• W2980732912 creator A5018478650 @default.
• W2980732912 creator A5019787392 @default.
• W2980732912 creator A5022279806 @default.
• W2980732912 creator A5028241466 @default.
• W2980732912 creator A5031590544 @default.
• W2980732912 creator A5033879584 @default.
• W2980732912 creator A5039970068 @default.
• W2980732912 creator A5043615700 @default.
• W2980732912 creator A5045047976 @default.
• W2980732912 creator A5052998014 @default.
• W2980732912 creator A5053075614 @default.
• W2980732912 creator A5066602987 @default.
• W2980732912 creator A5068328534 @default.
• W2980732912 creator A5071880070 @default.
• W2980732912 creator A5074157226 @default.
• W2980732912 creator A5084376077 @default.
• W2980732912 creator A5084643359 @default.
• W2980732912 creator A5085522760 @default.
• W2980732912 creator A5088736161 @default.
• W2980732912 creator A5091895459 @default.
• W2980732912 date "2020-11-27" @default.
• W2980732912 modified "2023-10-10" @default.
• W2980732912 title "Determinants of Patient‐Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association WithSex in 458 Patients From Fourteen Countries" @default.
• W2980732912 cites W1971721633 @default.
• W2980732912 cites W1980536183 @default.
• W2980732912 cites W2013573530 @default.
• W2980732912 cites W2033988686 @default.
• W2980732912 cites W2067902190 @default.
• W2980732912 cites W2102347458 @default.
• W2980732912 cites W2110846342 @default.
• W2980732912 cites W2117085331 @default.
• W2980732912 cites W2162563654 @default.
• W2980732912 cites W2186496667 @default.
• W2980732912 cites W2258730682 @default.
• W2980732912 cites W2474643945 @default.
• W2980732912 cites W2602427809 @default.
• W2980732912 cites W2604344665 @default.
• W2980732912 cites W2724955338 @default.
• W2980732912 cites W2765630054 @default.
• W2980732912 cites W2781962024 @default.
• W2980732912 cites W2790613941 @default.
• W2980732912 cites W2790916688 @default.
• W2980732912 cites W2798147550 @default.
• W2980732912 cites W2807775591 @default.
• W2980732912 cites W2809143647 @default.
• W2980732912 cites W2884544678 @default.
• W2980732912 doi "https://doi.org/10.1002/acr.24090" @default.
• W2980732912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7153974" @default.
• W2980732912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31609525" @default.
• W2980732912 hasPublicationYear "2020" @default.
• W2980732912 type Work @default.
• W2980732912 sameAs 2980732912 @default.
• W2980732912 citedByCount "29" @default.
• W2980732912 countsByYear W29807329122020 @default.
• W2980732912 countsByYear W29807329122021 @default.
• W2980732912 countsByYear W29807329122022 @default.
• W2980732912 countsByYear W29807329122023 @default.
• W2980732912 crossrefType "journal-article" @default.
• W2980732912 hasAuthorship W2980732912A5001947020 @default.
• W2980732912 hasAuthorship W2980732912A5005788294 @default.
• W2980732912 hasAuthorship W2980732912A5009722499 @default.
• W2980732912 hasAuthorship W2980732912A5012917558 @default.
• W2980732912 hasAuthorship W2980732912A5018478650 @default.
• W2980732912 hasAuthorship W2980732912A5019787392 @default.
• W2980732912 hasAuthorship W2980732912A5022279806 @default.
• W2980732912 hasAuthorship W2980732912A5028241466 @default.
• W2980732912 hasAuthorship W2980732912A5031590544 @default.
• W2980732912 hasAuthorship W2980732912A5033879584 @default.
• W2980732912 hasAuthorship W2980732912A5039970068 @default.
• W2980732912 hasAuthorship W2980732912A5043615700 @default.
• W2980732912 hasAuthorship W2980732912A5045047976 @default.
• W2980732912 hasAuthorship W2980732912A5052998014 @default.
• W2980732912 hasAuthorship W2980732912A5053075614 @default.
• W2980732912 hasAuthorship W2980732912A5066602987 @default.
• W2980732912 hasAuthorship W2980732912A5068328534 @default.
• W2980732912 hasAuthorship W2980732912A5071880070 @default.
• W2980732912 hasAuthorship W2980732912A5074157226 @default.
• W2980732912 hasAuthorship W2980732912A5084376077 @default.
• W2980732912 hasAuthorship W2980732912A5084643359 @default.
• W2980732912 hasAuthorship W2980732912A5085522760 @default.
• W2980732912 hasAuthorship W2980732912A5088736161 @default.
• W2980732912 hasAuthorship W2980732912A5091895459 @default.
• W2980732912 hasBestOaLocation W29807329123 @default.
• W2980732912 hasConcept C126322002 @default.
• W2980732912 hasConcept C16005928 @default.
• W2980732912 hasConcept C1862650 @default.
• W2980732912 hasConcept C2776260265 @default.
• W2980732912 hasConcept C2777077863 @default.
• W2980732912 hasConcept C2779134260 @default.
• W2980732912 hasConcept C2780564577 @default.
• W2980732912 hasConcept C71924100 @default.
• W2980732912 hasConceptScore W2980732912C126322002 @default.

• next